Ampersand Capital acquires Purna Pharmaceuticals
Achelous Partners acted as investment banking and financial adviser to Purna during the transaction.
Drug Development
Amgen receives EC approval for Uplizna in generalised myasthenia gravis
Citius Oncology and Uniphar sign European distribution deal for Lymphir
MSD receives FDA approval for Keytruda combo to treat ovarian cancer
THX Pharma and Biocodex sign licensing deal for Batten-1 and TX01 drugs
Insilico and CMS launch drug discovery collaborations for CNS diseases
REGENXBIO receives FDA response for RGX-121 application
Takeda and Iambic announce $1.7bn deal to advance small molecule programmes
